Prognostic Value of Lymph Node Staging With PSMA PET/CT and Extended PLND in Patients With Node-Positive Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The prognostic value of lymph node staging with prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and extended pelvic lymph node dissection in node-positive patients with prostate cancer
BJU Int 2022 Sep 07;[EPub Ahead of Print], D Meijer, RH Ettema, PJ van Leeuwen, TH van der Kwast, HG van der Poel, ML Donswijk, DE Oprea-Lager, EM Bekers, AN VisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.